Please select the option that best describes you:

How do you adjust medications for patients with eosinophilic esophagitis who responded to budesonide or PPI, and when do you repeat EGD?  

1. Repeat EGD after BID PPI is normal- do you decrease to once-a-day PPI? When to repeat EGD if ever?

2. After response to Budesonide, continue life-long vs taper vs switch to Dupilumamb?

3. Why not first-line Dupilumab?